Older human studies used short intravenous courses given in clinical settings
Cardiovascular risk reduction : Wegovy is covered by some plans, including Medicare Part D, when prescribed for cardiovascular risk reduction in patients with established heart disease and BMI 27 or higher
The enzyme aldose reductase which produces intermediate sorbitol is a NADPH requiring enzyme with a high Km for glucose [7], thus elevated intracellular glucose concentrations and an adequate supply of NADPH leads to a significant increase in the amount of sorbitol
Another trial, this one of exenatide, showed no significant changes in amyloid or tau in participants cerebrospinal fluid (the clear liquid around the brain) but it did find a reduction in amyloidbeta in extracellular vesiclespackages cells release to communicate with each otherwhich could be an early biomarker of Alzheimers disease, per the researchers
Goodman SI, Mace JW, Pollack S: Serum gamma-glutamyl transpeptidase deficiency